Stock Market Trading Analysis - Stock Market Trading Education - Options Trading - Stock
Market Analysis - Research & Stock Market Commentary
7/7/2012: More Upside for HGSI Celgene mulls Human Genome Sciences Exclusive Human Genome Sciences Inc. (HGSI) More Upside for HGSI Celgene mulls Human Genome Sciences Exclusive. Human Genome Sciences Inc (HGSI) shares climbed 5.36 percent to $14.35 in after-hours trading.
4/19/2012: Live Trading Premarket Commentary & Market Trends HGSI FFIVLive Trading Premarket Commentary & Market Trends HGSI FFIV. In this live trading video we'll cover what you need to watch in this monthly options expiration.
4/19/2012: Human Genome's 'Blockbuster' Potential Undervalued in Bid GSK vs HGSIHuman Genome's 'Blockbuster' Drug Benlystal Potential Undervalued in Bid by GSK vs HGSI BREAKING NEWS! Human Genome Rejects $2.6B Bid From GlaxoSmithKline (Update 1). The stock is currently trading at $14.50 up over 100%